Will last weekend’s moviegoing buzz about “Glicked” — the viral term that referenced the simultaneous U.S. releases of the ...
Investors are buying up crash protection for their portfolios even as a sizzling postelection rally shows few signs of ...
President-elect Donald Trump has assembled what might be called a team of rivals on economic policy. But investors should ...
Several of President-elect Donald Trump ‘s Cabinet picks and appointees have been targeted by bomb threats and “swatting ...
The Autorité des Marchés Financiers (AMF) has approved the first supplement to Veolia Environnement's (Paris:VIE) 2024 base prospectus in relation to the 18 billion euros Euro Medium Term Notes (EMTN) ...
Trump’s threatened tariffs on Canada and Mexico may boost inflation in the U.S., but there’s still “huge uncertainty” around ...
Oil futures finished on a mixed note, with U.S. and global benchmark prices little changed Wednesday as traders turned their ...
Tech was leading the way lower for stocks Wednesday. BTIG Chief Market Technician Jonathan Krinsky noted that while tech ...
It isn’t all bad news, said John Krinsky, chief market technician at BTIG, in a Wednesday client note. Tech’s XLK -1.62% 1.5% ...
Years ago, I was married to a doctor for 12 years. Clearly, he’s made much more than I have over our lifetimes. I’m 72 and he ...
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
An FDA complete response letter indicates that an application can't be approved in its current form. Govorestat, the company's lead drug candidate, is also being developed for treatment of sorbitol ...